4.7 Article

Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

Tangying Lu et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Immunology

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

Mercedes B. Fuertes et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Immunology

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Mark S. Diamond et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Biotechnology & Applied Microbiology

Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity

H. Komita et al.

CANCER GENE THERAPY (2009)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Review Biotechnology & Applied Microbiology

Immunotherapy of cancer by IL-12-based cytokine combinations

Jonathan M. Weiss et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2007)

Review Multidisciplinary Sciences

Taking dendritic cells into medicine

Ralph M. Steinman et al.

NATURE (2007)

Review Immunology

IDO expression by dendritic cells: Tolerance and tryptophan catabolism

AL Mellor et al.

NATURE REVIEWS IMMUNOLOGY (2004)